Net revenue grew 2% year-over-year to Rp246.3 trillion, with net profit stable at Rp33.4 trillion. The group maintained a strong balance sheet, completed a major healthcare acquisition, and distributed Rp21.0 trillion in dividends.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.